Valneva SE

Healthcare · Biotechnology · France

Last price 5.71 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 541.61M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Valneva SE, a specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs. It offers IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; DUKORAL, an oral vaccine for the prevention of diarrhea caused by Vibrio cholera or heat-labile toxin producing enterotoxigenic Escherichia coli bacterium; and IXCHIQ/ VLA1553, a single-dose, live-attenuated vaccine for the prevention of disease ca...